Top 50 Medical Angel Investors in United Kingdom (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Jonathan Milner
Angel
|
13 | United Kingdom, United States, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $537k–$56M |
|
Mark Bamforth
Angel
|
3 | United Kingdom, United States | Series A, Seed | Health Care, Medical, Biotechnology | $2M–$21M |
|
Will Martin
Angel
|
2 | United Kingdom, United States, Japan | Seed, Series A | Software, Financial Services, FinTech | $856k–$11M |
|
Matt Robinson
Angel
|
2 | United Kingdom, United States, France | Seed, Pre-Seed, Series A | Software, FinTech, Financial Services | $650k–$50M |
|
Michael Pennington
Angel
|
2 | United Kingdom, United States, Spain | Seed, Pre-Seed, Venture - Series Unknown | Software, SaaS, Financial Services | $701k–$3.1M |
|
Jan Hruska
Angel
|
2 | United Kingdom | Seed, Venture - Series Unknown | Medical, Health Care, Life Science | |
|
Alex Macdonald
Angel
|
2 | United Kingdom, United States, France | Pre-Seed, Seed, Series B | Software, Artificial Intelligence, Health Care | $327k–$50M |
|
Finn Russell
Angel
|
2 | United Kingdom | Angel, Venture - Series Unknown | Fitness, Medical, Wellness | |
|
Ian Hogarth
Angel
|
2 | United Kingdom, United States, Germany | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, SaaS | $698k–$43M |
|
Will Brooks
Angel
|
2 | United Kingdom, United States | Seed, Series A | Financial Services, FinTech, Software | $524k–$30M |
|
Ariel Poler
Angel
|
2 | United States, Spain, Mexico | Seed, Series A, Angel | Software, Social Media, Internet | $455k–$7.9M |
|
Alexander Chesterman
Angel
|
2 | United Kingdom, France | Seed, Pre-Seed, Series A | FinTech, E-Commerce, Financial Services | $470k–$23M |
|
Matt Clifford
Angel
|
2 | United Kingdom, United States, India | Seed, Pre-Seed | Software, FinTech, Artificial Intelligence | $55k–$7M |
|
Nicholas Edwards
Angel
|
2 | United Kingdom | Seed, Venture - Series Unknown | Medical, Health Care, Life Science | |
|
Taavet Hinrikus
Angel
|
2 | United Kingdom, United States, Estonia | Seed, Series A, Series B | FinTech, Software, Financial Services | $1.6M–$58M |
|
Simon Franks
Angel
|
1 | United Kingdom, Australia, United States | Seed, Pre-Seed, Series A | FinTech, Health Care, Payments | $318k–$23M |
|
Ian Noel
Angel
|
1 | Spain, United States, United Kingdom | Seed, Series A | Pet, Education, Film | |
|
Jag Singh
Angel
|
1 | Germany, United Kingdom, United States | Pre-Seed, Seed, Angel | Software, FinTech, Artificial Intelligence | $120k–$4.5M |
|
Adam Niewinski
Angel
|
1 | Poland, Singapore, United States | Series A, Seed, Series B | FinTech, Financial Services, Artificial Intelligence | $2M–$65M |
|
Martin Varsavsky
Angel
|
1 | United States, United Kingdom, Spain | Seed, Series A, Angel | Software, Health Care, Social Media | $212k–$77M |
|
Tim Davis
Angel
|
1 | United States, United Kingdom, Germany | Series A, Series B, Seed | Health Care, Biotechnology, Medical | |
|
David Evans
Angel
|
1 | Israel, United States, United Kingdom | Series A, Series D, Series E | Software, SaaS, Rental | |
|
John Lloyd
Angel
|
1 | United Kingdom | Seed, Equity Crowdfunding | Health Care, Wellness, Education | $196k–$655k |
|
Julien Codorniou
Angel
|
1 | France, United Kingdom, United States | Seed, Series A, Pre-Seed | Software, E-Commerce, Artificial Intelligence | $125k–$23M |
|
Nadav Rosenberg
Angel
|
1 | United Kingdom, France, Israel | Seed, Pre-Seed, Series A | Biotechnology, Artificial Intelligence, Software | $850k–$19M |
|
Mart Abramov
Angel
|
1 | United Kingdom | Pre-Seed | Legal, Legal Tech, Marketplace | |
|
Patrick Bamford
Angel
|
1 | United Kingdom | Series A | B2C, Shoes, Sporting Goods | |
|
Jon Moulton
Angel
|
1 | United Kingdom, Cyprus, Luxembourg | Seed, Series A | Financial Services, FinTech, Banking | |
|
Duncan Grierson
Angel
|
1 | United Kingdom | Seed, Series A | Water, Medical, CleanTech | |
|
Richard Reed
Angel
|
1 | United Kingdom, United States | Seed, Series A | Content, Food and Beverage, Pharmaceutical | |
|
Flavien Kulawik
Angel
|
1 | France, United Kingdom | Seed, Series A | Health Care, Artificial Intelligence, SaaS | |
|
Pa Nolan
Angel
|
1 | Ireland, United Kingdom | Seed | Medical, Delivery, Shipping | |
|
Arthur Chen
Angel
|
1 | United Kingdom | Seed, Series A | Medical, Chemical, Software | |
|
Emilio Püschmann
Angel
|
1 | United Kingdom | Pre-Seed | Medical, Database, Consulting | |
|
John Taysom
Angel
|
1 | United Kingdom, United States | Seed, Angel, Series A | Software, Information Technology, Artificial Intelligence | |
|
Sidar Sahin
Angel
|
1 | United Kingdom | Series A | Medical, mHealth, Health Care | |
|
Andrew MacKay
Angel
|
1 | United Kingdom | Seed | Medical, Hospital, Health Care | |
|
Henry Carleton
Angel
|
1 | United Kingdom | Series A | Medical, Health Care, Health Diagnostics | |
|
Sachin Agrawal
Angel
|
1 | United Kingdom | Series A | Medical, Health Care, Health Diagnostics | |
|
Johnathan Matlock
Angel
|
1 | United Kingdom | Seed, Pre-Seed | Biotechnology, Medical, Health Care | |
|
Jim Mellon
Angel
|
1 | United States, United Kingdom, Israel | Series A, Seed | Biotechnology, Health Care, Food and Beverage | |
|
Brian Souter
Angel
|
1 | United Kingdom | Medical, Commercial, Health Care | ||
|
Yusuf Hamied
Angel
|
1 | United Kingdom | Seed | Medical, Medical Device | |
|
Carlos Ballarati
Angel
|
1 | United Kingdom | Pre-Seed | Medical, Database, Consulting | |
|
Anand Mahindra
Angel
|
1 | India, United States, United Kingdom | Seed, Angel, Series A | Education, Artificial Intelligence, Social Media | |
|
Charlotte Scott
Angel
|
1 | United Kingdom | Seed | Medical, Health Care, Pharmaceutical | |
|
Phil Kirby
Angel
|
1 | United Kingdom | Seed | Medical, Hospital, Medical Device | |
|
Harry Glorikian
Angel
|
1 | United States | Series A | SaaS, Content, Analytics | |
|
Peter Job
Angel
|
1 | United Kingdom | Medical, Software, Pharmaceutical | ||
|
Michael Bibby
Angel
|
1 | United Kingdom | Seed | Medical, Hospital, Medical Device | |
| Access all 155 angel investors in United Kingdom Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 62
- Round size: Seed $537k–$25M; Series A $4.1M–$50M; Series B $1.6M–$56M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
- Nuclera — Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Mark Robert Bamforth is based out of Boston, Massachusetts and is the Chief Executive Officer of disAMR and Executive Advisor of Ampersand Capital Partners. Mark previously worked at Kincell Bio as a Chief Executive Officer. Mark Robert Bamforth attended the Henley Business School.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 15
- Round size: Seed $2M–$7M; Series A $9.2M–$21M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Dxcover — Dxcover are a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
- Thymmune Therapeutics — Thymmune Therapeutics is developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease.
- CONTINUUS Pharmaceuticals — CONTINUUS Pharmaceuticals works with pharmaceutical and generic companies under a Build-Own-Operate model. They design, build, and run the manufacturing process directly at the client site. This novel business model provides its clients with an exceptional, ”one-shop solution” for their entire development and manufacturing cycle. CONTINUUSPharmaceuticals is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through an $85 M joint research project between Novartis and MIT. In addition, the company is currently collaborating with hospital systems and pharmacy chains to establish its own generic business, where high-quality, low-cost drugs will be manufactured in the United States.
Will Martin - Founder and Director @ Portfolio Ventures
Show more...Investment focus
- Industry: Software, Financial Services, FinTech
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Japan
Investor stats
- Total investments: 104
- Round size: Seed $856k–$5.5M; Series A $2.2M–$11M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bequest — Digital estate planning made easy for professionals and individuals. Securely protect online accounts, cryptocurrencies, emails, media, documents and more.
- Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
- Robin — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.
Matt Robinson is the CEO and a co-founder at Nested, a property technology company. Prior to this, he founded GoCardless in 2010 and remains on the board of the recurring payment company.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 78
- Round size: Seed $2M–$7.9M; Pre-Seed $650k–$3M; Series A $6M–$50M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Malga — Malga is an online payment platform that offers fraud protection and payment split services.
- Feather — Feather gives you insurance advice for expats in Germany. Our digital insurance agent will help you get the right insurance policies for your need.
- Malga — Instant access to multiple payment providers with a single integration
One of the UK's leading tech angel investors. Active seed and pre-seed stage angel investor in UK based disruptive tech. Prefers businesses venturing into pastures new and keen investing at the pre product stage whether BtoC or B2B. Twice exited UK based tech entrepreneur with experience operating tech businesses in 20 countries in multiplelanguages. Co-founded Gumtree with Simon Crookall which was acquired by Ebay and Slando acquired by Naspers.
Show more...Investment focus
- Industry: Software, SaaS, Financial Services
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 37
- Round size: Seed $750k–$3.1M; Pre-Seed $701k–$2.1M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Hubflo — Hubflo is building an all-in-one work OS to help small businesses manage their business. Instead of having 10 complicated and expensive pieces of software, Hubflo offers SMB everything they need to run their business (CRM, projects, invoicing, expenses...) in a single comprehensive, simple and affordable platform.
- Tetra AI — Tetra AI is a health technology firm that has created an AI-powered software platform designed to assist hospitals in managing surgical waiting lists and operating room schedules. The system evaluates patient lists, staff availability, and theatre capacity to generate optimized surgical plans that minimize delays and improve resource utilization.It is mainly employed by NHS hospitals and operational teams to enhance elective care performance within the limits of available resources.
- Sidekick — Expertly-managed portfolios for the modern investor
Jan Hruska
Show more...Investment focus
- Industry: Medical, Health Care, Life Science
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Alex Macdonald is the Co-Founder and CEO Sequel. He previously Co-Founded Velocity Black. He attended The University of Manchester.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Pre-Seed, Seed, Series B
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 48
- Round size: Seed $1.2M–$8.5M; Pre-Seed $327k–$2.5M; Series B $11M–$50M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kalder — Kalder is a unified web3 brand loyalty platform for brands and creators to drive meaningful engagement, onboard new users, and reward superfan communities.
- Stelia — Stelia builds distributed AI platforms that scale globally. Research-driven intelligent systems for healthcare, education, and enterprise operations worldwide
- Aurora — The Operating System for High Performance Living
Finn Russell is a Scottish rugby union player.
Show more...Investment focus
- Industry: Fitness, Medical, Wellness
- Stage:Angel, Venture - Series Unknown
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Puresport — Puresport was created to craft the finest, premium-quality natural products to support every element of wellbeing, from pain & recovery, to sleep, focus, mood, stress, and balance.
Ian Hogarth is based out of London, England, and is the Chairman of Phasecraft. Ian previously worked at Songkick as a Chairman. Ian Hogarth attended the University of Cambridge.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 60
- Round size: Seed $1.5M–$7.9M; Pre-Seed $698k–$7.5M; Series A $11M–$43M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
- Cordless — Bridging the gap between voice and text
- Fabric — Fabric is an AI-powered workspace and file manager for people and groups.Fabric is a self-organizing multiplayer workspace.
Will Brooks - Founder & Director @ Portfolio Ventures
Show more...Investment focus
- Industry: Financial Services, FinTech, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 69
- Round size: Seed $524k–$3.1M; Series A $2.2M–$30M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bequest — Digital estate planning made easy for professionals and individuals. Securely protect online accounts, cryptocurrencies, emails, media, documents and more.
- Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
- Robin — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children.
Show more...Investment focus
- Industry: Software, Social Media, Internet
- Stage:Seed, Series A, Angel
- Geography: United States, Spain, Mexico
Investor stats
- Total investments: 45
- Round size: Seed $455k–$7M; Angel $1M–$1.7M; Series A $3M–$7.9M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Goin — Goin is a Barcelona-based fintech platform founded in 2017 that provides a unified money optimization ecosystem combining automated savings, investments, digital assets, and rewards. The app enables users to aggregate multiple bank accounts via PSD2, centralizing financial data and automating decisions through its AI engine, gaIA. Goin integratesfinancial automation, portfolio tools, and cash-back incentives in a single interface used primarily by young European consumers. The company operates in a regulated environment, is registered with the Bank of Spain as a crypto service provider, and has expanded across Southern Europe. In 2025, Goin launched KernelPay, its B2B Banking-as-a-Service (BaaS) infrastructure for payments, accounts, and wallet management.
- Reloadly — Send gift cards, airtime & payouts globally with one API. Scalable, instant, developer-friendly platform for rewards and incentives.
- Openlytics — Openlytics is a Visual Data Platform. It allows Data Workers to create pipelines for data transformation and analysis, in a visual way. Our mission is to empower everyone in the organization to solve data problems, without waiting for developers.Openlytics is an early-stage company, looking to build a founding team that can shape the direction ofthe product. We’re seed-funded, remote-first, and hiring.If you're interested in learning more, email us at hello@openlytics.io.
Alex Chesterman is the Co-Founder of Houseful. Alex Chesterman attended the University College London.
Show more...Investment focus
- Industry: FinTech, E-Commerce, Financial Services
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, France
Investor stats
- Total investments: 43
- Round size: Seed $524k–$4.8M; Pre-Seed $470k–$3M; Series A $2.3M–$23M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Atheni AI — Guided AI adoption: the thinking of a top consultancy, the 1:1 personalisation of a coach, delivered at the scale of a platform. Capability, not access. Independent by design.
- Zefir — An all-in-one platform that allows people to sell or buy in one simple, certain transaction
- Pharmacierge — Pharmacierge is the award-winning digital e-prescribing service chosen by private clinicians to deliver medication to their patients throughout the UK and worldwide. Clinicians create and transfer e-prescriptions to our pharmacy near London's Harley Street, for free delivery to their patients.
Matt co-founded EF after being a consultant at McKinsey & Co. Prior to EF Matt spent his time studying at MIT fuelled by an obsession with R, Python and unusual datasets. EF is the best place for Europe’s top technical individuals to meet and build world-changing startups in London.They select purely on the basis of technical talent, so youcan apply before you have a team or an idea. The intensive 6-month programme is designed to give you the best possible support in the first 200 days of your startup’s life.They have created over 40 startups now worth over $300 million. The startups are funded by some prestigious investors including Balderton Capital, Index Ventures, Octopus Investments and Y Combinator.
Show more...Investment focus
- Industry: Software, FinTech, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, United States, India
Investor stats
- Total investments: 40
- Round size: Seed $764k–$7M; Pre-Seed $55k–$4.2M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Stackfix — Stackfix operates as a software comparison platform.
- Rivan Industries — Rivan Industries designs and builds modular, vertically integrated, synthetic fuel plants.
- Asymmetric Security — Asymmetric Security is an AI-native cybersecurity startup specializing in digital forensics and incident response. It combines elite forensic experts with proprietary AI to accelerate investigations, especially Business Email Compromise (BEC) attacks, at less than half the cost of competitors while shrinking timelines from days to hours.
Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.
Show more...Investment focus
- Industry: Medical, Health Care, Life Science
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Taavet Hinrikus is based out of London, England and is the Partner of Plural Platform and Board Member of CoMind. Taavet previously worked at Wise as a Chairman and Co-founder. Taavet Hinrikus attended INSEAD.
Show more...Investment focus
- Industry: FinTech, Software, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Estonia
Investor stats
- Total investments: 133
- Round size: Seed $1.6M–$10M; Series A $6.4M–$45M; Series B $23M–$58M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Habito — We're the Treating Customers Fairly Champion of 2023 as voted for in the British Bank Awards. We're here to make mortgages easier - no paperwork, no stress and no fees.
- Lassie — AI that runs the doctor's office.
- Lightyear — Lightyear is a simple and approachable way to invest your money globally without unnecessary barriers and fees.
Simon Franks is the founder and managing partner of Redbus Ventures and Chairman of the Franks Family Foundation. (www.thefff.org)
Show more...Investment focus
- Industry: FinTech, Health Care, Payments
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 54
- Round size: Seed $524k–$5.7M; Pre-Seed $318k–$1.6M; Series A $5.4M–$23M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- Auro — Auro is a mobile fitness-tech solution providing you with a personal trainer in your ear. We believe that fitness is at its effective best, when it is personalized, engaging, and accessible anytime. We break down the barriers to exercise by providing millions of people all over the world access to a personal trainer along with the best of contentthat boutique studio fitness has to offer.We’re creating a truly motivating, connected fitness experience that keeps people coming back for more by combining world class instructors, killer playlists and data science led personalisation.Our mission is to transform lives by making fitness experiences awesome, accessible and affordable.
- Thriva — At-home blood testing and science-backed next steps to feel great, maximise your performance, and extend your healthspan.
- Lick — Lick | Paints, Wallpapers and Supplies. Your Room, Covered
Ian Noel - Angel & Growth Investor @ Lingokids
Show more...Investment focus
- Industry: Pet, Education, Film
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 6
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Oja.la — Oja.la is an online learning platform for computer skills in Latin America. Oja.la has developed 1,500 classes.- 70 tech programs, released 16 new programs last month and are planning to double the new release of new courses monthly.
- Holidog — Holidog specializes in the fields of pet sitting, pet boarding, pet walking, giftbox, pet media, and startups. It features a software platform that allows pet owners to interact and find the perfect pet sitters, dog walkers, nannies, or trainers at their convenience and close to their home.It was founded in 2012 and headquartered in New York,United States.
- Lingokids — Voted #1 Kids Learning App, Lingokids is the best app for kids 2-8 years old! Because when learning is fun, kids love to learn! Check it out!
Jag is one of Europe's most active angel investors, and is a Managing Partner at Angel Invest Ventures in Berlin. He's founded several companies (including two exits and a spectacular failure), and invested in over 100 startups over the last six years, including Spire (SPAC), Nutmeg (exit to JPM), Disperse, Eversend, Restack, and Anytype.He’s an ad-man at heart, and spent over a decade as a political strategist advising high-profile politicians, campaigns and corporations across the US and Europe. Jag is fluent in six languages, and can be found on Twitter via @JagSingh
Show more...Investment focus
- Industry: Software, FinTech, Artificial Intelligence
- Stage:Pre-Seed, Seed, Angel
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 95
- Round size: Seed $180k–$4.5M; Angel $153k–$382k; Pre-Seed $120k–$1.9M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Konfetti — konfetti is building the leading platform for local workshops and events by empowering workshop providers with customized SaaS solutions
- Strange Loop Labs — Guru automates tax, insurance, and audit processes with generative AI
- Lightning Reach — Lightning Reach is a financial support portal that makes it easy for people to find and apply for a wide range of personalised support in one place. This support can range from; charitable grants, local council schemes, help with bills and the cost of living crisis and benefits.
Adam Niewinski is based out of Warsaw, Mazowieckie, and is the Co-Founder & General Partner of OTB Ventures. Adam previously worked at Xelion Investment House as the Chairman of the Supervisory Board. Adam Niewinski attended the SGH Warsaw School of Economics.
Show more...Investment focus
- Industry: FinTech, Financial Services, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Poland, Singapore, United States
Investor stats
- Total investments: 21
- Round size: Seed $2M–$10M; Series A $6.2M–$65M; Series B $8.8M–$34M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- ITaxi — ITaxi is a free mobile application, allowing its users to order cabs through its application. Its users do not have to know Polish to use the application as they can decide by type and model of the car, rate per kilometer, and time.ITaxi cooperates with local taxi federations and it has fleet of 10, 000 vehicles in over 100 cities all over thecountry, including Warsaw, Cracow, Lodz, Wroclaw, Gdansk, and Poznan. Launched in 2012 the application is based in Poland.
- OrganOx — OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford.
- Audioteka — Audioteka is a mobile and multi-language audiobook application for smartphones/tablets with a dedicated audiobook car platform. They offer audiobooks in 9 languages in 23 countries.They strive to bring stories back into the lives of busy people through the creative use of technologies. They want everyone to try an audiobook at least once.They're confident you'll enjoy this new medium. People really can be smarter and better entertained thanks to their stories.They edit and produce audiobooks, collaborate with actors, inspire new and innovative productions and in doing so they offer unique content that can’t be found in any other audiobook store. Audioteka strives to give its customers the highest quality content via ready-to-use mobile solutions. They understand their mobile users and continue to learn from them every day. That is why they've created the world's most seamless platform for enjoying valuable spoken word content while on the go!
Martin Varsavsky is the Founder and Chairman of Gameto. He previously worked at Fon as a Chairman. Martin Varsavsky attended Columbia Business School.
Show more...Investment focus
- Industry: Software, Health Care, Social Media
- Stage:Seed, Series A, Angel
- Geography: United States, United Kingdom, Spain
Investor stats
- Total investments: 25
- Round size: Seed $424k–$3.3M; Angel $212k–$1.1M; Series A $4.3M–$77M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Humand — Discover our all-in-one HR solution. Experience the best HR software for digital transformation and enjoy the benefits of centralizing internal procedures!
- Shorta — Descubre series cortas de drama, comedia, romance y suspenso en Shorta y empieza a ver hoy mismo, con nuevos episodios cada semana.
- Betterness — Betterness is Augmented Wellness: intelligence for people, providers, and builders across the Betterness app, Betterness One, and the developer stack.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Timothy T Davis, MD is Board Certified in Physical Medicine and Rehabilitation (Physiatry) and Pain Medicine. The founder of Source Healthcare, Source Surgery Center, Alpha Diagnostics and he is an expert in spine and musculoskeletal disorders as well as interventional pain management to treat neck, back and sports injuries. Dr. Davis hasperformed extensive clinical research using biological therapies such as stem cells and other biologics for spine and joint injuries. He has consulted and invested in SaaS, medical device, biologics, cannabis, and psychedelics sectors.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 10
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bryn Pharma — Bryn Pharma is a pharmaceutical company that offers nasal-based epinephrine for anaphylaxis. Its bi-dose intranasal device is an alternative to epinephrine auto-injectors and is needle-free. It is easy to use and portable enabling patients to treat allergic reactions or anaphylactic reactions.
- Beckley Psytech — Our mission is to help people suffering from neurological and psychiatric conditions by developing our pipeline of psychedelic compounds.
- MycoMedica Life Sciences, PBC — Psychedelic Medicines
Principal at Apax Digital.
Show more...Investment focus
- Industry: Software, SaaS, Rental
- Stage:Series A, Series D, Series E
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 4
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- Guesty — Guesty simplifies the way property managers work.
- Inspectorio — We allow Brands, Retailers, Vendors and Factories to improve Quality, Compliance and Delivery operations with tangible insights and data-driven collaboration.
- MIP Diagnostics — MIP Diagnostics develop and manufacture molecularly imprinted polymers (nanoMIPs) that act as synthetic alternatives to antibodies for IVD and other industries.
John Lloyd
Show more...Investment focus
- Industry: Health Care, Wellness, Education
- Stage:Seed, Equity Crowdfunding
- Geography: United Kingdom
Investor stats
- Total investments: 6
- Round size: Seed $196k–$655k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Thrive — Thrive Mental Wellbeing - Mental Health Services
- Easy Peasy — Get EasyPeasy parenting tips and activities, personalised for you and your 0-5 year old, from our playful community of parents and experts.
- Elemental Software — Elemental is a digital platform that connects patients health and social care professionals and community health & wellness providers.Health Professionals are able to generate digital social prescriptions for citizens with chronic health risks such as depression, social isolation, type 2 diabetes and obesity, connecting them with qualityassured providers who deliver community based interventions across the domains of exercise, diet/nutrition, social support and mental health.The software is designed as a multi-tenanted cloud service and so can be implemented rapidly. It is highly parameterised and can be customised to suit an individual organisation's functional requirements without compromising its technological core.
Julien is an investor at Felix Capital where he focuses on SaaS (Worktech in particular) and gaming investments.Before joining Felix, Julien Codorniou spent 11 years at Facebook where he led the global platform partnerships team, helping Facebook partners to build, grow and monetize their mobile apps and games. From 2016 to 2021, he has beenserving as Vice President of Workplace. Under his leadership, Workplace went from 0 to 9 million paid subscribers at companies like Walmart, Grab, GSK, Nestlé, Chevron, MercadoLibre, ServiceNow, Astrazeneca, Lixil, Spotify, Save the Children and many more globally. Julien started his career in finance and before Facebook he was Director of Business Development at Microsoft Corp.Since 2012, Julien has served on the board of the French media group Le Monde. He is the co-author of the book: "The Kelkoo.com success story"published by Pearson in 2005.His former investments, as business angel include companies like TripleDot Studios, Bloom & Wild, Pigment, Xentral, Homesome, Olio, Peanut, Nabla, Curio, Linktree, Airlift Technologies and Sunday.He grew up in France and now lives in London with his wife and their two boys.
Show more...Investment focus
- Industry: Software, E-Commerce, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: France, United Kingdom, United States
Investor stats
- Total investments: 55
- Round size: Seed $1M–$8M; Pre-Seed $125k–$2.7M; Series A $3.3M–$23M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Claimy — Integrate Claimy to unlock the full potential of your catalogue, recover missing royalties, and gain real-time insights into your performances.
- Jolly — Jolly is a rewards platform for the workplace that incentivizes employee performance. It implements performance-based incentives to increase employees utilization, compliance, referrals, and loyalty.
- Arlequin AI — Unlock actionable insights from complex social data to drive strategic decisions using our AI models.
Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.
Show more...Investment focus
- Industry: Biotechnology, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, France, Israel
Investor stats
- Total investments: 15
- Round size: Seed $850k–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$19M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Qantev — Qantev is the leading AI claims platform for health & life insurance, enabling insurers to automate claims operations, reduce leakage, improve loss ratios, enhance data quality, and elevate customer experience.
- thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
- Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
Mart Abramov - Co-founder/ CEO @ TaxScouts
Show more...Investment focus
- Industry: Legal, Legal Tech, Marketplace
- Stage:Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Legal Nodes — Offload your legal tasks to a virtual legal department and get on with running your business. Get started with the Legal Nodes platform for free.
- Emerald — Take control of your long-term health with Emerald. Get continuous GP support, in-depth screenings, wearable data integration, and a personalised plan to prevent disease and boost longevity.
Patrick Bamford
Show more...Investment focus
- Industry: B2C, Shoes, Sporting Goods
- Stage:Series A
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Emerald — Take control of your long-term health with Emerald. Get continuous GP support, in-depth screenings, wearable data integration, and a personalised plan to prevent disease and boost longevity.
- Hylo Athletics — Hylo Athletics manufactures Athletic Footwear.
Jon Moulton is a British venture capitalist. He is the founder and managing partner of the private equity firm Better Capital, and is the former managing partner of the private equity firm Alchemy Partners.
Show more...Investment focus
- Industry: Financial Services, FinTech, Banking
- Stage:Seed, Series A
- Geography: United Kingdom, Cyprus, Luxembourg
Investor stats
- Total investments: 18
- Lead/follow: no public data
Portfolio highlights
- Pockit — Open a prepaid account in 3 minutes online or in-app, get your contactless prepaid card in 2 working days with no credit check.
- Hometree — Keep yourself warm with Hometree, and try our no price hike promise. Compare our different boiler & home cover plans to see how you can save.
- Hellas Direct — Hellas Direct is a digital-first, full-stack insurance company, empowered by cutting-edge technology and artificial intelligence. The Cyprus-based company is backed by a roster of leading investors, including Portag3, IFC (a member of the World Bank), Endeavor Catalyst, former Goldman Sachs economist Lord O’Neill and private equity veteran JonMoulton. Modelling itself on Amazon, Hellas Direct aims to disrupt the insurance value chain by adopting an extreme focus on operational excellence.
Duncan Grierson
Show more...Investment focus
- Industry: Water, Medical, CleanTech
- Stage:Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Puraffinity — Puraffinity develops targeted materials for water treatment, focused on forever chemicals called PFAS. Our strategic intent is to provide 1 billion people with PFAS safe water by 2030
- Moixa Technology — Moixa Technology develops the Maslow intelligent energy storage solution, enabling homes to store energy and benefit from revenue streams generated by trading energy through GridShare, an SaaS platform that aggregates energy from groups of Maslow energy storage systems. . The company develops smart DC technologies to power DC lighting, computing,electronics from grid-shifted storage or local PV from smart DC hubs, variable DC networks and sockets. The technology and IPR reduces grid peak by shifting DC device load and powering DC devices efficiently without inverters or AC/DC adaptors, together with providing smart control and energy management. The technology aims to address the 1 trillion kwh + lost annually in power conversion, and the significant growing DC demand in homes, offices from ICT, LED lighting and the rise in internet connected devices.
Richard is the founder of Innocent Drinks, UK's number 1 smoothie brand. In 2009 The Coca-Cola Company acquired a minority stake in Innocent Drinks and in 2013 the stake was increased to over 90%. Innocent Drinks gives 10% of its profits to charity. Richard is known to have implemented a google-like working atmosphere at InnocentDrinks' offices, where people feel like at home. He appeared in sereval high profile TV shows and documentaries, here is a documentary with Peter Jones from Drangon's Den (UK's equivalent of Shark Tank) He is now a successful investor through his company JamJar Investments, where they invest in strong teams with an idea that consumers love.
Show more...Investment focus
- Industry: Content, Food and Beverage, Pharmaceutical
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 14
- Lead/follow: no public data
Portfolio highlights
- Simba Sleep — One Mattress. Five Layers of Comfort. Tailored to Suit All. Bringing together experience & technology so that your mattress gives you the best night's sleep.
- Beckley Psytech — Our mission is to help people suffering from neurological and psychiatric conditions by developing our pipeline of psychedelic compounds.
- Beckley Canopy Therapeutics — Beckley Canopy Therapeutics is a biopharmaceutical company designed to research cannabis health products.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Flavien Kulawik
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, SaaS
- Stage:Seed, Series A
- Geography: France, United Kingdom
Investor stats
- Total investments: 11
- Lead/follow: no public data
Portfolio highlights
- Adionics — Adionics provides advances ionic solutions such as lithium and iodide extraction, and salts separation.
- Biomemory — Biomemory creates DNA Drives for large corporates and administrations.
- Scienta Lab — Redefining precision immunology
Pa Nolan
Show more...Investment focus
- Industry: Medical, Delivery, Shipping
- Stage:Seed
- Geography: Ireland, United Kingdom
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- SiSaf — SiSaf delivers on the promise of RNA therapeutics with Bio-Courier technology.
- Scurri — Scurri is next generation delivery management software that puts retailers back in control. Explore our delivery management software today.
Arthur Chen is a Managing Partner at Ameba Capital.
Show more...Investment focus
- Industry: Medical, Chemical, Software
- Stage:Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Porotech — All-in-One MicroLEDs for Everyone, Everywhere, Every Device Unleashing the Power of Light Our MicroLED technology revolutionises the way displays are manufactured, making microLED displays possible for everyone. Through our partnerships and dedicated R&D teams we develop new technologies and can succeed together with you. compare to the conventional LED Porotech is here for your every
- Pangaea Data — Find & connect with more patients, at scale, for therapies, clinical trials and drug discovery studies.
Emilio Püschmann
Show more...Investment focus
- Industry: Medical, Database, Consulting
- Stage:Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- OPEN Health — OPEN Health is a healthcare agency that provides market access strategy, health economic modeling and meta-analysis patient engagement, patient-centered outcomes, real-world evidence and data analytics, medical affairs consultancy and strategy, publications planning and delivery, scientific, communications, learning and development.
John Taysom started the Reuters Venture Capital Fund in Palo Alto in 1995 making 82 investments in internet and web infrastructure and services including Verisign, UltraDNS, Digimarc, ZeroKnowledge and Intertrust. He was a member of the Board of Digimarc pre and post its Nasdaq IPO, a Board member at Intertrust and a Board member at TIBCO throughits Nasdaq IPO. To date, seventeen of his investments have achieved an IPO.John acquired the Fund in an MBO in 2002. Now London-based with a seed portfolio of thirty US and UK start-ups; one has achieved an IPO and several have been acquired by Experian, Linkedin, Tesco, BMC and others.In 2011 and 2012 John took a Fellowship at Harvard to work on privacy issues and holds EU and US patents on a method of improving privacy online. For 2015 John is a Policy Fellow at the University of Cambridge Centre for Science and Policy and a Visiting Professor, Department of Computer Science, at UCL. He is a member of the Board of the Web Science Trust; chairs Performance Horizon, a fast growing UK startup; is a Governor at Hurstpierpoint College; and runs a small farm in Devon.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Angel, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 16
- Lead/follow: no public data
Portfolio highlights
- LGN — LGN's edge AI management software puts you in complete technical and financial control of your edge AI systems.
- Tenyks — Tenyks gives Computer Vision Engineers the insights to build more reliable models faster! Collaborate to identify and fix dataset issues. Improve data quality. Boost model performance. No more wondering in the dark.
- Worldr — Valarian | Innovating for the new era of digital sovereignty
Sidar Sahin is Founder & CEO at Peak Games.
Show more...Investment focus
- Industry: Medical, mHealth, Health Care
- Stage:Series A
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Anima — Anima's online patient triage speeds up the clinical workflow 10x and allows providers to deliver the right care for patients within 24 hours.Millions of patients with serious problems are missed and die every year because there isn’t adequate information flow between medical appointments. Patients submit their problems and requests onAnimainstead of waiting for an appointment, and Anima sends an actionable report to their provider with trends, risks and recommendations.
Andrew MacKay
Show more...Investment focus
- Industry: Medical, Hospital, Health Care
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- MyHealthPal — MyHealthPal is a health & wellbeing app to promote healthy living and help you manage your own or other people's health conditions.
- Materials Nexus — Accelerating change to net-zero materials
Henry is a trained doctor with extensive hospital experience who co-founded Four Eyes Insight to put his talent for finding strategic solutions and planning into helping the NHS.His interest in medical resource management developed during his junior doctor training at Bart’s and the Royal London and he helped trusts tackle the significantchallenges of rotas and the New Deal as Junior Doctors’ Advisor at the London Regional Action Team.Establishing Zircadian Ltd, a software development company focusing on a portfolio of solutions to help NHS organisations plan and organise their medical workforce more strategically and effectively in 2000, he sold it on 11 years later to Allocate with over 140 NHS clients using its products.
Show more...Investment focus
- Industry: Medical, Health Care, Health Diagnostics
- Stage:Series A
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.
Sachin Agrawal
Show more...Investment focus
- Industry: Medical, Health Care, Health Diagnostics
- Stage:Series A
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.
Johnathan Matlock is Co-Founder Science Angel Syndicate.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 10
- Lead/follow: no public data
Portfolio highlights
- OutSee — We are well-versed in a variety of genomics, AI and cohort analysis techniques. We are also bioinformatics generalists and work with just about any ...
- EnsiliTech — EnsiliTech is a biotechnology start-up developing ensilication, a platform technology, to remove the need for refrigeration when transporting and storing vaccines and biologicals
- Halo Therapeutics — Halo Therapeutics is based in England. Develops safe pan coronavirus antiviral drugs for Covid-19 that can be administered by patients.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Food and Beverage
- Stage:Series A, Seed
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 28
- Lead/follow: no public data
Portfolio highlights
- Voxia — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
- Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
- The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.
Sir Brian Souter is co-founder and Chairman of Stagecoach plc, having retired as Chief Executive in May 2013.Whilst he does not sit with the Souter Investments team in Edinburgh, Sir Brian is active in all investment decision making processes and sits on the boards of our European bus operators (PolskiBus.com and OnniBus.com) and New Zealandtransport group (InMotion).Sir Brian is currently the Vice-President of the Institute of Chartered Accountants of Scotland.
Show more...Investment focus
- Industry: Medical, Commercial, Health Care
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Ryboquin — Ryboquin™ uses its expertise to turn under-developed intellectual property ideas into viable commercial realities. Founded in Scotland, Ryboquin Ltd is a privately held, virtual pharmaceutical company focused on commercialising patented technologies in the area of human cancer medicine.Founded in Scotland, Ryboquin is a privately held, virtualpharmaceutical company focused on commercializing patented technologies in the area of human cancer medicine.
Yusuf Hamied is a Cambridge-educated Chemist and the Non-Executive Chairman of the Board of Directors at Cipla, a large generic pharmaceuticals company founded in 1935 by his father, Khwaja Abdul Hamied. Yusuf became a global celebrity for his role in defying Western multinational pharmaceutical companies in order to provide generic AIDS treatmentsand other drugs to treat poor people in the developing world. After completing his doctorate in 1960, Yusuf joined the family company and vowed to break the dominance of foreign multinationals over the Indian pharmaceutical market by developing cheap generic drugs. Yusuf helped persuade the Indian government to change Indian patent law in 1972, permitting medicines to be copied even if they were under international patent, as long as the process was not the same. The law transformed the Indian pharmaceutical industry, enabling his and other companies to grow by manufacturing generic drugs. In 2001 Yusuf convulsed the global healthcare industry by promising and then delivering a triple drug cocktail, Triomune, that helped fight against HIV and AIDS at prices far lower than those available internationally. Yusuf discusses his subsequent anger when, in 2005, the Indian government brought its patent laws in line with those of the developed world, prohibiting the copying of drugs patented after 1995 without a license and his resentment that he had thereafter “to go with a begging bowl to the multinationals” for licenses. This interview provides not only a personal perspective on how India’s third largest pharmaceutical firm was created, but contributes to the broad debates on the costs and benefits of intellectual property laws, particularly their impact on people who are denied life-saving drugs by their inability to pay for them. Working for Cipla as Managing Director for nearly 52 years, Yusuf was also the 28th richest Indian during one time. ‘CNN-IBN Indian of the year’ and one among the ’25 greatest global living legends’ were the titles that Yusuf won for his reign in the pharma world majorly for making medicines affordable to the poor. Yusuf was awarded with the civil honorary Padma Bhushan from then president APJ Abdul Kalam in the year 2005 for his fight against AIDS, which he often said was going to be as damaging to the society as a massive earthquake would be, if ignored. Yusuf earned his Bachelor's degree (1956), Master's degree (1957) and Ph.D. (1960) in Chemistry from University of Cambridge.
Show more...Investment focus
- Industry: Medical, Medical Device
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- 1inhaler — 1inhaler operates as a developer of drug delivery device.
Carlos Ballarati - Founding partner @ Consulta do Bem
Show more...Investment focus
- Industry: Medical, Database, Consulting
- Stage:Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- OPEN Health — OPEN Health is a healthcare agency that provides market access strategy, health economic modeling and meta-analysis patient engagement, patient-centered outcomes, real-world evidence and data analytics, medical affairs consultancy and strategy, publications planning and delivery, scientific, communications, learning and development.
Graduate, Harvard Univ. and Harvard Business School. Chairman and Managing Director, Mahindra Group. Thought leader in Indian business. Serves on many industry confederations. Initiated the Nanhi Kali programme to provide free education to economically underprivileged girls in India. Co-Founder, Naandi Danone, India's largest safe drinkingwater provider to rural areas. Life Trustee, Board of Naandi Foundation, which provides meals to 1.3 million children daily. Co-Chair, World Economic Forum Annual Meeting 2009. Named among World’s 50 Greatest Leaders, Fortune Magazine (2014); named one of the top 25 most powerful business people in Asia, Fortune Magazine (2011).
Show more...Investment focus
- Industry: Education, Artificial Intelligence, Social Media
- Stage:Seed, Angel, Series A
- Geography: India, United States, United Kingdom
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- Agnikul — Agnikul Cosmos designs and manufactures orbital-class launch vehicles powered by 3D-printed engines. From custom payloads to affordable private launches, we make space access simple, scalable, and mission-focused.
- Harvested Robotics — Harvested Robotics is an ag-tech company that focuses on safeguarding farms from weeds and diseases by lasers, robotics, and AI technology.
- Genrobotics Medical & Mobility — India's top-rated gait trainer, G Gaiter! Our AI-powered, robot assisted gait trainer accelerates neurorehabilitation for faster recovery.
Charlotte Scott
Show more...Investment focus
- Industry: Medical, Health Care, Pharmaceutical
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Phil founded Health Intelligence in 1996 and maintains a vital role in the company shaping strategy and innovation. After graduating from Keele with an MBA on the Health Executive Programme, Phil spent thirteen years in the NHS as a senior manager responsible for I.T., registration and screening functions. This experience from within the NHS andprivate sector has given him an in-depth understanding of how cross sector population-based solutions can help the NHS overcome key challenges.
Show more...Investment focus
- Industry: Medical, Hospital, Medical Device
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- AI-Sight — AI Sight Limited delivers next-generation AI-powered diabetic eye screening to enhance accuracy, speed, and accessibility across healthcare systems
Harry Glorikian is the General Partner at Scientia Ventures.
Show more...Investment focus
- Industry: SaaS, Content, Analytics
- Stage:Series A
- Geography: United States
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- MarketMuse — Our AI-powered software tells you what content to write (and how much) to leverage your experience and rank higher where competitors are weak.
- Emerald — Take control of your long-term health with Emerald. Get continuous GP support, in-depth screenings, wearable data integration, and a personalised plan to prevent disease and boost longevity.
- Transparency Life Sciences — Transparency Life Sciences, the first all-digital clinical development services company, harnesses crowdsourcing and mobile health technology to advance biopharma drug candidates through clinical trials with unprecedented patient relevance and efficiency.The TLS model is highly scalable and is designed to increase current industry margins of awasteful process that often collects irrelevant data. Drug companies will outsource an estimated $38B of clinical trial services to CROs by 2020, with a CAGR of 9-10%. Yet this robust growth masks significant customer dissatisfaction. Sponsors want clinical trials to be better-designed, technologically advanced, patient-centric, and significantly less expensive, yet change has been limited by an inability to see beyond the current outmoded, site-centric model.As a consequence, only select compounds are being developed in humans, leaving many potential important therapies untested in clinical trials. Rapid advances in digital technology and strong regulatory support create a historic opportunity for TLS to catalyze a fundamental transformation, significantly improving the quality of clinical trials while reducing their cost.
Peter Job is an angel investor.
Show more...Investment focus
- Industry: Medical, Software, Pharmaceutical
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Pangaea Data — Find & connect with more patients, at scale, for therapies, clinical trials and drug discovery studies.
Michael Bibby is Chairman at Bibby Line Group Ltd.
Show more...Investment focus
- Industry: Medical, Hospital, Medical Device
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- AI-Sight — AI Sight Limited delivers next-generation AI-powered diabetic eye screening to enhance accuracy, speed, and accessibility across healthcare systems
Medical Angel investor funding in United Kingdom at a glance
Stats across 123 deals from 155 investors.
Access all 155 angel investors in United Kingdom Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Angel Investors in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 155 angel investors investing in United Kingdom Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!